• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病早期的突触功能障碍。

Synaptic dysfunction in early phases of Alzheimer's Disease.

机构信息

Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy.

Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy.

出版信息

Handb Clin Neurol. 2022;184:417-438. doi: 10.1016/B978-0-12-819410-2.00022-9.

DOI:10.1016/B978-0-12-819410-2.00022-9
PMID:35034752
Abstract

The synapse is the locus of plasticity where short-term alterations in synaptic strength are converted to long-lasting memories. In addition to the presynaptic terminal and the postsynaptic compartment, a more holistic view of the synapse includes the astrocytes and the extracellular matrix to form a tetrapartite synapse. All these four elements contribute to synapse health and are crucial for synaptic plasticity events and, thereby, for learning and memory processes. Synaptic dysfunction is a common pathogenic trait of several brain disorders. In Alzheimer's Disease, the degeneration of synapses can be detected at the early stages of pathology progression before neuronal degeneration, supporting the hypothesis that synaptic failure is a major determinant of the disease. The synapse is the place where amyloid-β peptides are generated and is the target of the toxic amyloid-β oligomers. All the elements constituting the tetrapartite synapse are altered in Alzheimer's Disease and can synergistically contribute to synaptic dysfunction. Moreover, the two main hallmarks of Alzheimer's Disease, i.e., amyloid-β and tau, act in concert to cause synaptic deficits. Deciphering the mechanisms underlying synaptic dysfunction is relevant for the development of the next-generation therapeutic strategies aimed at modifying the disease progression.

摘要

突触是可塑性的发生部位,在这里短期的突触强度变化可以转化为长期记忆。除了突触前末梢和突触后区,对突触的更全面的认识还包括星形胶质细胞和细胞外基质,它们共同构成了四联体突触。所有这四个元素都有助于突触的健康,对于突触可塑性事件以及学习和记忆过程至关重要。突触功能障碍是几种脑部疾病的常见致病特征。在阿尔茨海默病中,突触的退化可以在神经元退化之前的病理进展的早期阶段被检测到,这支持了突触衰竭是疾病的主要决定因素的假说。突触是淀粉样β肽生成的地方,也是有毒淀粉样β寡聚体的靶标。构成四联体突触的所有元素在阿尔茨海默病中都发生了改变,并可能协同导致突触功能障碍。此外,阿尔茨海默病的两个主要标志,即淀粉样β和 tau,协同作用导致突触缺陷。解析突触功能障碍的机制对于开发旨在改变疾病进展的下一代治疗策略具有重要意义。

相似文献

1
Synaptic dysfunction in early phases of Alzheimer's Disease.阿尔茨海默病早期的突触功能障碍。
Handb Clin Neurol. 2022;184:417-438. doi: 10.1016/B978-0-12-819410-2.00022-9.
2
Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.阿尔茨海默病发病机制中的氧化应激与突触功能障碍:理解治疗策略
Mol Neurobiol. 2016 Jan;53(1):648-661. doi: 10.1007/s12035-014-9053-6. Epub 2014 Dec 17.
3
The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.阿尔茨海默病中谷氨酸能突触功能障碍和崩溃中淀粉样β和 tau 的交汇。
Ageing Res Rev. 2013 Jun;12(3):757-63. doi: 10.1016/j.arr.2013.03.002. Epub 2013 Mar 22.
4
Alzheimer's disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression.阿尔茨海默病作为一种突触病:疾病进展过程中突触功能障碍的证据。
Front Synaptic Neurosci. 2023 Mar 9;15:1129036. doi: 10.3389/fnsyn.2023.1129036. eCollection 2023.
5
Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future.代谢型谷氨酸受体在阿尔茨海默病突触功能障碍中的作用:治疗机遇与未来希望。
J Alzheimers Dis. 2020;78(4):1345-1361. doi: 10.3233/JAD-201146.
6
The synapse as a treatment avenue for Alzheimer's Disease.作为阿尔茨海默病治疗途径的突触
Mol Psychiatry. 2022 Jul;27(7):2940-2949. doi: 10.1038/s41380-022-01565-z. Epub 2022 Apr 20.
7
Synapses and dendritic spines as pathogenic targets in Alzheimer's disease.突触和树突棘作为阿尔茨海默病的致病靶点。
Neural Plast. 2012;2012:247150. doi: 10.1155/2012/247150. Epub 2012 Feb 6.
8
Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.阿尔茨海默病是突触前功能衰竭的结果吗?寡聚β-淀粉样蛋白诱导的突触功能障碍。
Rev Neurosci. 2009;20(1):1-12. doi: 10.1515/revneuro.2009.20.1.1.
9
Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.雷公藤氯内酯醇通过减少淀粉样β蛋白并上调阿尔茨海默病转基因模型中与突触相关的蛋白质来改善认知缺陷。
J Neurochem. 2015 Apr;133(1):38-52. doi: 10.1111/jnc.13056. Epub 2015 Mar 8.
10
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.细胞朊蛋白介导β-淀粉样寡聚体对突触可塑性的损害。
Nature. 2009 Feb 26;457(7233):1128-32. doi: 10.1038/nature07761.

引用本文的文献

1
The Alzheimer's disease risk gene is a regulator of excitatory neuronal function.阿尔茨海默病风险基因是兴奋性神经元功能的调节因子。
bioRxiv. 2025 Jul 29:2025.07.28.667194. doi: 10.1101/2025.07.28.667194.
2
Integrated multi-omics analyses of synaptosomes revealed synapse-associated novel targets in Alzheimer's disease.对突触体的综合多组学分析揭示了阿尔茨海默病中与突触相关的新靶点。
Mol Psychiatry. 2025 Jun 28. doi: 10.1038/s41380-025-03095-w.
3
A positive allosteric modulator of the SERCA pump rescues hippocampal neuronal circuits dysfunction and cognitive defects in a mouse model of Alzheimer's disease.
SERCA泵的正变构调节剂可挽救阿尔茨海默病小鼠模型中的海马神经元回路功能障碍和认知缺陷。
J Neurosci. 2025 Jun 24. doi: 10.1523/JNEUROSCI.2337-24.2025.
4
MicroRNA-502-3p Modulates the GABA A Subunits, Synaptic Proteins, and Mitochondrial Morphology in Hippocampal Neurons.微小RNA-502-3p调节海马神经元中的γ-氨基丁酸A型受体亚基、突触蛋白和线粒体形态。
Mol Neurobiol. 2025 Jun 19. doi: 10.1007/s12035-025-05130-x.
5
Let-7 Family as a Mediator of Exercise on Alzheimer's Disease.Let-7家族作为运动对阿尔茨海默病影响的介导因子
Cell Mol Neurobiol. 2025 May 19;45(1):43. doi: 10.1007/s10571-025-01559-9.
6
Endocytic Pathways Unveil the Role of Syndecans in the Seeding and Spreading of Pathological Protein Aggregates: Insights into Neurodegenerative Disorders.内吞途径揭示了聚糖在病理性蛋白质聚集体的播种和传播中的作用:对神经退行性疾病的见解。
Int J Mol Sci. 2025 Apr 24;26(9):4037. doi: 10.3390/ijms26094037.
7
FTO inhibition mitigates high-fat diet-induced metabolic disturbances and cognitive decline in SAMP8 mice.FTO抑制减轻了高脂饮食诱导的SAMP8小鼠的代谢紊乱和认知衰退。
Mol Med. 2025 Feb 21;31(1):73. doi: 10.1186/s10020-025-01126-4.
8
Nonlinear mixed-effects models to analyze actin dynamics in dendritic spines.用于分析树突棘中肌动蛋白动力学的非线性混合效应模型。
Sci Rep. 2025 Feb 17;15(1):5790. doi: 10.1038/s41598-025-87154-w.
9
CNEURO-201, an Anti-amyloidogenic Agent and σ1-Receptor Agonist, Improves Cognition in the Mouse Model of Alzheimer's Disease by Multiple Actions in the Pathology.CNEURO-201,一种抗淀粉样蛋白生成剂和σ1受体激动剂,通过在病理过程中的多种作用改善阿尔茨海默病小鼠模型的认知能力。
Int J Mol Sci. 2025 Feb 3;26(3):1301. doi: 10.3390/ijms26031301.
10
Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer's Disease.短双歧杆菌MCC1274作为阿尔茨海默病新疗法的保护作用
Nutrients. 2025 Jan 31;17(3):558. doi: 10.3390/nu17030558.